Will Lewis, Insmed CEO, joins 'Fast Money' to talk the rare disease pipeline, acquisitions in the pharma space, and more.
MedPage Today on MSN
New CDC Guidance Could Revive a Rare but Deadly Disease
The new CDC recommendation takes a much narrower view of the meningococcal disease threat. Because of "the low incidence ...
Dr. Ali Raja says risk-based vaccines have helped keep meningitis rates low; however, public health experts believe if ...
After years stuck in the “doldrums,” the biopharma sector is in a “very good place” heading into the new year, analysts told ...
The loved one is 32-year-old Hani Duglof, who is now being treated at M Health Fairview Southdale Hospital while still in ICE ...
The Priority Review Voucher (PRV) program is designed to incentivize rare disease drug development.
Grey's Anatomy's Steven W. Bailey, who starred as bartender Joe on Grey's Anatomy, revealed he was diagnosed with Congenital ...
Fox Business on MSN
AI genome sequencing could transform rare disease diagnosis: GeneDx CEO
GeneDx CEO Katherine Stueland discusses the company’s AI-driven partnership with Komodo Health, the push to speed rare ...
Minister Dr. Jitendra Singh says India is shifting to genomic healthcare. Through the 2021 Rare Disease Policy, the nation is ...
| Servier is committing to rare neurology for the long term, using focused science and strategic collaborations to bring new ...
U.S. commercial launch in thalassemia underway following December 2025 FDA approvalPre-sNDA meeting with FDA for mitapivat in sickle cell disease anticipated in first quarter of 2026, with planned U.S ...
Genetic treatments could be the key to unlocking some rare diseases. But bringing these medicines to patients involves ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback